Epidural Contrast Flow Patterns of TESI Using the Inferior-Anterior Position as the Final Needle Tip Position.
- Conditions
- Lumbar Herniated Nucleus PulposusLumbosacral Radiculopathy
- Registration Number
- NCT01836770
- Lead Sponsor
- George Washington University
- Brief Summary
The purpose of this study is to describe the contrast flow patterns in the epidural space using the inferior-anterior approach with continuous fluoroscopic guidance, and determine how well this approach correlates with appropriate contrast flow patterns and with analgesia at follow up. This knowledge may prove useful in guiding physician practice patterns in the non-surgical management of low back pain.
Hypothesis: The investigators hypothesize that there will be suitable (ventral/anterior) epidural contrast spread based on inferior-anterior needle-tip position, particularly with appropriate needle tip position.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 5
- 18 years of age or older
- History of lumbosacral radiculopathy or lumbar herniated nucleus pulposus
- Scheduled for TFESI at GW Spine and Pain Center
- Pregnant or plan on becoming pregnant
- Have undergone TFESI in the past year
- Opioid habituation
- Lumbo-sacral stenosis
- Lumbar surgery
- Lumbar spondylolisthesis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Contrast flow patterns 3 Months Contrast flow patterns will be used as the primary outcome measure. The statistical test to be employed is to compare the proportions of patients in the study who experienced posterior flow, anterior flow and if that anterior flow had spread to more than 1 vertebral level in either direction, what that direction was, and the presence or absence of vascular flow.
- Secondary Outcome Measures
Name Time Method VAS pain score 3 months VAS Pain Score - The statistical test to be employed is Wilcoxon Signed Rank Test to compare if there is a difference in pain score at appointments 1 months and 3 months post-injection relative to pre-injection.
Trial Locations
- Locations (1)
George Washington Spine and Pain Center
🇺🇸Washington, District of Columbia, United States